↓ Skip to main content

Aripiprazole versus other atypical antipsychotics for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
28 tweeters
weibo
1 weibo user
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
267 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aripiprazole versus other atypical antipsychotics for schizophrenia
Published in
Cochrane database of systematic reviews, January 2014
DOI 10.1002/14651858.cd006569.pub5
Pubmed ID
Authors

Priya Khanna, Tao Suo, Katja Komossa, Huaixing Ma, Christine Rummel-Kluge, Hany G El-Sayeh, Stefan Leucht, Jun Xia

Abstract

In most western industrialised countries, second generation (atypical) antipsychotics are recommended as first-line drug treatments for people with schizophrenia. In this review, we specifically examine how the efficacy and tolerability of one such agent - aripiprazole - differs from that of other comparable second generation antipsychotics.

Twitter Demographics

The data shown below were collected from the profiles of 28 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 267 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 <1%
Denmark 2 <1%
United Kingdom 1 <1%
South Africa 1 <1%
Brazil 1 <1%
Guatemala 1 <1%
Uruguay 1 <1%
Chile 1 <1%
Japan 1 <1%
Other 0 0%
Unknown 256 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 48 18%
Researcher 34 13%
Student > Bachelor 31 12%
Student > Ph. D. Student 30 11%
Student > Doctoral Student 22 8%
Other 69 26%
Unknown 33 12%
Readers by discipline Count As %
Medicine and Dentistry 110 41%
Psychology 22 8%
Nursing and Health Professions 18 7%
Pharmacology, Toxicology and Pharmaceutical Science 18 7%
Agricultural and Biological Sciences 16 6%
Other 39 15%
Unknown 44 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2018.
All research outputs
#560,074
of 13,649,352 outputs
Outputs from Cochrane database of systematic reviews
#1,718
of 10,696 outputs
Outputs of similar age
#10,761
of 255,398 outputs
Outputs of similar age from Cochrane database of systematic reviews
#24
of 162 outputs
Altmetric has tracked 13,649,352 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,696 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 255,398 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 162 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.